Phosphorus announced that it is partnering with healthcare platform provider BioIQ to make its at-home COVID-19 saliva diagnostic test accessible across the U.S.
BioIQ will connect employees and healthcare plan members to Phosphorus' at-home test, which was recently granted an emergency use authorization from the U.S. Food and Drug Administration. Additionally, BioIQ has developed a platform to support assessment of symptoms and exposure, contact tracing, and follow-up care navigation. Tests may be ordered online.